Changho Han

878 total citations
25 papers, 544 citations indexed

About

Changho Han is a scholar working on Molecular Biology, Pharmaceutical Science and Organic Chemistry. According to data from OpenAlex, Changho Han has authored 25 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 6 papers in Organic Chemistry. Recurrent topics in Changho Han's work include Fluorine in Organic Chemistry (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Changho Han is often cited by papers focused on Fluorine in Organic Chemistry (6 papers), Receptor Mechanisms and Signaling (5 papers) and Neuroscience and Neuropharmacology Research (4 papers). Changho Han collaborates with scholars based in United States, Denmark and Italy. Changho Han's co-authors include David A. Colby, Eun Hoo Kim, Craig W. Lindsley, Shaun R. Stauffer, Gregory H. Hockerman, Jolanta Grembecka, Rocco D. Gogliotti, Julia A. Chester, Tomasz Cierpicki and Xinyi Jiang and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Communications and Journal of Medicinal Chemistry.

In The Last Decade

Changho Han

22 papers receiving 541 citations

Peers

Countries citing papers authored by Changho Han

Since Specialization

Citations

This map shows the geographic impact of Changho Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changho Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changho Han more than expected).

Fields of papers citing papers by Changho Han

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changho Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changho Han. The network helps show where Changho Han may publish in the future.

Co-authorship network of co-authors of Changho Han

This figure shows the co-authorship network connecting the top 25 collaborators of Changho Han. A scholar is included among the top collaborators of Changho Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changho Han. Changho Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of Deuterium in an M₁ Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422 2025 ·ACS Chemical Neuroscience ·Julie L. Engers, (unknown), Changho Han, (unknown), Alison R. Gregro, (unknown), Jonathan W. Dickerson, Weimin Peng, Hyekyung P. Cho, Alice L. Rodriguez, Zixiu Xiang, Olivier Boutaud, C. O’Carroll, Prabuddha Dey, Ethan S. Burstein, Colleen M. Niswender, Jerri M. Rook, P. Jeffrey Conn, Darren W. Engers, Craig W. Lindsley	0
2	Discovery of a Novel sp³-Rich M₁ Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping 2025 ·ACS Medicinal Chemistry Letters ·(unknown), Paul K. Spearing, (unknown), (unknown), (unknown), Sichen Chang, (unknown), Analisa D. Thompson, Hyekyung P. Cho, Peng Li, Alice L. Rodriguez, Colleen M. Niswender, Olivier Boutaud, Valerie M. Kramlinger, Carrie K. Jones, P. Jeffrey Conn, Julie L. Engers, Darren W. Engers, Craig W. Lindsley, Changho Han	0
3	Discovery and Characterization of VU0542270, the First Selective Inhibitor of Vascular Kir6.1/SUR2B KATP Channels 2024 ·Molecular Pharmacology ·(unknown), (unknown), Changho Han, (unknown), (unknown), Olivier Boutaud, Joshua A. Bauer, Emily Days, Craig W. Lindsley, Elaine L. Shelton, Jerod S. Denton	4
4	Structure-Based Discovery of Potent, Orally Bioavailable Benzoxazepinone-Based WD Repeat Domain 5 Inhibitors 2023 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Jianhua Tian, Changho Han, Kenneth M. Meyers, Jiqing Sai, (unknown), (unknown), (unknown), John Sensintaffar, Bin Zhao, Kangsa Amporndanai, William Moore, Gordon M. Stott, William P. Tansey, Taekyu Lee, Stephen W. Fesik	7
5	Synthesis and SAR of a novel Kir6.2/SUR1 channel opener scaffold identified by HTS 2023 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), (unknown), (unknown), Sichen Chang, (unknown), Emily Days, Joshua A. Bauer, Hyekyung P. Cho, Olivier Boutaud, Jerod S. Denton, Craig W. Lindsley, Changho Han	0
6	Discovery of a potent M5 antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists 2022 ·Bioorganic & Medicinal Chemistry Letters ·Douglas L. Orsi, Andrew S. Felts, Alice L. Rodriguez, Paige N. Vinson, Hyekyung P. Cho, Sichen Chang, Anna L. Blobaum, Colleen M. Niswender, P. Jeffrey Conn, Carrie K. Jones, Craig W. Lindsley, Changho Han	1
7	VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels 2022 ·Molecular Pharmacology ·(unknown), (unknown), Sujay V. Kharade, (unknown), (unknown), Changho Han, Andrew S. Terker, (unknown), Roman M. Lazarenko, Emily Days, Ian M. Romaine, Joshua A. Bauer, Olivier Boutaud, Gary A. Sulikowski, (unknown), C. David Weaver, Alexander Staruschenko, Craig W. Lindsley, Jerod S. Denton	10
8	Discovery of a potent M5 antagonist with improved clearance profile. Part 1: Piperidine amide-based antagonists 2022 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Douglas L. Orsi, Andrew S. Felts, Alice L. Rodriguez, Paige N. Vinson, Sichen Chang, Anna L. Blobaum, Colleen M. Niswender, P. Jeffrey Conn, Carrie K. Jones, Craig W. Lindsley, Changho Han	2
9	Generation of formaldehyde and formaldehyde-d₂ for hydroxymethylations and hydroxydeuteromethylations of difluoroenolates and difluorobenzyl carbanions 2022 ·Chemical Communications ·(unknown), Changho Han, (unknown), (unknown), Md Baharul Islam, David A. Colby	3
10	Discovery of VU6028418: A Highly Selective and Orally Bioavailable M₄ Muscarinic Acetylcholine Receptor Antagonist 2021 ·ACS Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Changho Han, (unknown), Alice L. Rodriguez, Peng Li, Jonathan W. Dickerson, Aidong Qi, Jerri M. Rook, (unknown), (unknown), Sichen Chang, Thomas M. Bridges, Julie L. Engers, Darren W. Engers, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Aaron M. Bender	7
11	DARK Classics in Chemical Neuroscience: Loperamide 2021 ·ACS Chemical Neuroscience ·(unknown), Craig W. Lindsley, Changho Han	3
12	Controlling the Cleavage of Carbon–Carbon Bonds To Generate α,α-Difluorobenzyl Carbanions for the Construction of Difluoromethylbenzenes 2019 ·The Journal of Organic Chemistry ·(unknown), Changho Han, (unknown), Xiaoliang Pan, (unknown), (unknown), Yihan Shao, David A. Colby	7
13	Discovery of Tricyclic Triazolo- and Imidazopyridine Lactams as M₁ Positive Allosteric Modulators 2018 ·ACS Chemical Neuroscience ·Julie L. Engers, Aaron M. Bender, (unknown), Hyekyung P. Cho, (unknown), Vincent B. Luscombe, Changho Han, Bruce J. Melancon, Anna L. Blobaum, Jonathan W. Dickerson, Jerri M. Rook, Colleen M. Niswender, Kyle A. Emmitte, P. Jeffrey Conn, Craig W. Lindsley	5
14	Progress towards small molecule menin-mixed lineage leukemia (MLL) interaction inhibitors with in vivo utility 2015 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Rocco D. Gogliotti, Changho Han, Charles W. Locuson, Ryan D. Morrison, J. Scott Daniels, Tomasz Cierpicki, Jolanta Grembecka, Craig W. Lindsley, Shaun R. Stauffer	11
15	Progress towards small molecule inhibitors of the Menin-Mixed Lineage Leukemia (MLL) interaction with in vivo utility 2015 ·Europe PMC (PubMed Central) ·(unknown), Rocco D. Gogliotti, Changho Han, Charles W. Locuson, Ryan D. Morrison, J. Scott Daniels, Tomasz Cierpicki, Jolanta Grembecka, Craig W. Lindsley, Shaun R. Stauffer	1
16	Discovery and SAR of muscarinic receptor subtype 1 (M1) allosteric activators from a molecular libraries high throughput screen. Part 1: 2,5-Dibenzyl-2H-pyrazolo[4,3-c]quinolin-3(5H)-ones as positive allosteric modulators 2014 ·Bioorganic & Medicinal Chemistry Letters ·Changho Han, Arindam Chatterjee, Meredith J. Noetzel, Joseph D. Panarese, Emery Smith, Peter Chase, Peter Hodder, Colleen M. Niswender, P. Jeffrey Conn, Craig W. Lindsley, Shaun R. Stauffer	6
17	Evaluation of Difluoromethyl Ketones as Agonists of the γ-Aminobutyric Acid Type B (GABA_B) Receptor 2013 ·Journal of Medicinal Chemistry ·Changho Han, (unknown), Eun Hoo Kim, Xinyi Jiang, (unknown), (unknown), (unknown), (unknown), Julia A. Chester, Gregory H. Hockerman, David A. Colby	90
18	Cleaving Carbon-Carbon Bonds by the Release of Trifluoroacetate to Remodel Molecules and Assemble Fluorinated Structures 2012 ·Synlett ·David A. Colby, Changho Han, Eun Sun Kim	6
19	The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma 2011 ·Leukemia & lymphoma ·(unknown), John T. Williams, (unknown), Michael J. Iannotti, Changho Han, (unknown), Stephen E. Kendall, Carlotta A. Glackin, David A. Colby, Julia Kirshner	62
20	Cleavage of Carbon−Carbon Bonds through the Mild Release of Trifluoroacetate: Generation of α,α-Difluoroenolates for Aldol Reactions 2011 ·Journal of the American Chemical Society ·Changho Han, Eun Hoo Kim, David A. Colby	150

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact